Named on 4 rounds in the feed, most often in Biotech.
Rounds from 2018-06-06 to 2026-10-28
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Micronano Core A Hangzhou-based AI chip developer | Series C Verified against 4 of 5 sources | $150.1M | 2026-10-28 | [ PART ] |
Abcuro Breakthrough therapies for autoimmune diseases and cancer for patients with specific conditions. | Series D Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $66M | 2026-08-18 | [ PART ] |
PaXini Paxini offers embodied intelligence data solutions and robotic products, targeting both researchers and businesses in the field of robotics and AI. | Series B Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $144.8M | 2026-03-06 | [ LEAD ] |
Astrocyte Pharmaceuticals A clinical-stage biotechnology company developing first-in-class cerebroprotective therapies for concussion, traumatic brain injury (TBI) and stroke | Pre-A Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $2.3M | 2018-06-06 | [ LEAD ] |